Document is current
Any future updates will be listed below
-
Authors
Leocadi, Michela
Canu, Elisa
Donzuso, Giulia
Stojkovic, Tanja
Basaia, Silvia
Kresojević, Nikola
Stankovic, Iva
Sarasso, Elisabetta
Piramide, Noemi
Tomic, Aleksandra
Markovic, Vladana
Petrovic, Igor
Stefanova, Elka
Kostic, Vladimir S.
Filippi, Massimo
Agosta, Federica https://orcid.org/0000-0003-3121-4979
-
Funding
Funding for this research was provided by:
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (#175090)
Ministero della Salute (RF-2018-12366746)
- License Information
-
More Information
Article History
Received: 14 April 2021
Revised: 23 June 2021
Accepted: 11 July 2021
First Online: 23 July 2021
Declarations
:
: M. Leocadi, G. Donzuso, S. Basaia, N. Kresojević, E. Sarasso, N. Piramide, V. Markovic, and I. Stankovic report no disclosures. E. Canu has received research supports from the Italian Ministry of Health. T. Stojkovic and E. Stefanova have received Alzheimer Association grant for Promoting Diversity, from 2018 and honoraria from Actavis. A. Tomic has received honoraria for serving as a consultant to and on the advisory board of Univar BV. I. Petrovic has received speaker honoraria from Actavis and Salveo. V.S. Kostic has received speaker honoraria from Roche and Alkaloid and receives research supports from the Swiss Pharm and Serbian Ministry of Education, Science, and Development and Serbian Academy of Sciences and Art. M. Filippi is Editor-in-Chief of the Journal of Neurology and Associate Editor of Human Brain Mapping; received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). F. Agosta is Section Editor of NeuroImage: Clinical; received compensation for consulting services and/or speaking activities from Philips, Novartis, Biogen Idec and Roche; and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council.
: This study was approved by the Local Ethical Committees on human studies and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All subjects’ parents provided written informed consent prior to study participation.
